Key Publications

Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience. Krueger DA, Capal JK, Curatolo P, Devinsky O, Ess K, Tzadok M, Koenig MK, Narayanan V, Ramos F, Jozwiak S, de Vries P, Jansen AC, Wong M, Mowat D, Lawson J, Bruns S, Franz DN; TSCure Research Group. Eur J Paediatr Neurol. 2018 Jul 4 [Epub ahead of print]

Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial, Koenig M; Bell C; Hebert A; Roberson J; Samuels J; Slopis J; Tate P; Northrup H; for the TREATMENT Trial Collaborators, 2018, JAMA Dermatology

Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial, Curatolo P; Franz DN; Lawson JA; Yapici Z; Ikeda H; Polster T; Nabbout R; de Vries PJ; Dlugos DJ; Fan J, 2018, A The Lancet Child and Adolescent Health, vol. 2, pp. 495 - 504

The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: A review, Chan DL, Calder T, Lawson JA, Mowat D, Kennedy SE, 2018, Reviews in the Neurosciences, vol. 29, pp. 295 – 301

Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures, Franz DN; Lawson JA; Yapici Z; Brandt C; Kohrman MH; Wong M; Milh M; Wiemer-Kruel A; Voi M; Coello N, 2018, Epilepsia, vol. 59, pp. 1188 - 1197

Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome, Chung CWT, Lawson JA, Sarkozy V, Riney K, Wargon O, Shand AW, Cooper S, King H, Kennedy SE, Mowat D, 2017, Pediatric Neurology, vol. 76, pp. 20 - 26

Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex, Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA, 2014, Journal of Pediatrics, vol. 164, pp. 1195 – 1200

Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Krueger DA, Northrup H; International Tuberous Sclerosis Complex Consensus Group. Pediatr Neurol. 2013 Oct;49(4):255-65.

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Pediatr Neurol. 2013 Oct;49(4):243-54.

An Australian tuberous sclerosis cohort: are surveillance guidelines being met? Chopra M, Lawson JA, Wilson M, Kennedy SE, Taylor P, Buckley MF, Wargon O, Parasivam G, Camphausen C, Yates D, Mowat D. J Paediatr Child Health. 2011 Oct;47(10):711-6.